MedPath

POTASSIUM CHLORIDE BP - ADDITIVE FOR CONCENTRATED HAEMODIALYSIS SOLUTIONS

POTASSIUM CHLORIDE BP - ADDITIVE FOR CONCENTRATED HAEMODIALYSIS SOLUTIONS

Discontinued
DIN Number

02230681

Drug Class

Human

Market Date

Jun 18, 1998

Company
HC

genpharm ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02230681
AIG Number0100273035
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05ZA HEMODIALYTICS, CONCENTRATES
Product Specifications
Dosage FormPowder
Route of AdministrationHaemodialysis
AHFS Classification40:34.00*
Health Canada Classification

ACTIVE INGREDIENTS (1)

POTASSIUM CHLORIDEActive
Strength: 12.5 G / VIAL
Monograph: POTASSIUM CHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.